(Q30754957)

26 June 2017

1 reference

title

Ethical, and practical issues in applying functional imaging to the clinical management of Alzheimer's disease (English)

1 reference

26 June 2017

0 references

0 references

1 reference

4

Jerome A Yesavage

1 reference

26 June 2017

2

Arun L W Bokde

1 reference

26 June 2017

Allyson C Rosen

1

1 reference

PubMed ID

12480493

26 June 2017

Allison Pearl

series ordinal

3

1 reference

PubMed ID

12480493

26 June 2017

language of work or name

1 reference

1 December 2002

1 reference

26 June 2017

1 reference

26 June 2017

50

1 reference

26 June 2017

3

1 reference

26 June 2017

498-519

1 reference

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The variability of human, BOLD hemodynamic responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The MacArthur Treatment Competence Study. I: Mental illness and competence to consent to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Functional changes in brain activity during priming in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Identifying Correlates of Accident Involvement for the Older Driver

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Conceptual processing during the conscious resting state. A functional MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Patterns of brain activation in people at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Making memories: brain activity that predicts how well visual experience will be remembered.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Functional brain imaging of young, nondemented, and demented older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Randomized event-related experimental designs allow for extremely rapid presentation rates using functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Hemispheric asymmetry reduction in older adults: the HAROLD model

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Reproducibility of fMRI results across four institutions using a spatial working memory task

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Stability, repeatability, and the expression of signal magnitude in functional magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The effect of normal aging on the coupling of neural activity to the bold hemodynamic response.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Cognitive function and the costs of Alzheimer disease. An exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Level of sustained entorhinal activity at study correlates with subsequent cued-recall performance: a functional magnetic resonance imaging study with high acquisition rate

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The effects of aging upon the hemodynamic response measured by functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Synaptic density in human frontal cortex — Developmental changes and effects of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Prevalence of AD among whites: a summary by levels of severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Invasiveness in studies of brain function by positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

FMRI of visual encoding: reproducibility of activation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Functional MRI studies of word-stem completion: reliability across laboratories and comparison to blood flow imaging with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Three Cases of Enduring Memory Impairment after Bilateral Damage Limited to the Hippocampal Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Visual attention impairments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Loss of recent memory after bilateral hippocampal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

A preliminary assessment of the medical and functional factors associated with vehicle crashes by older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

When zero is not zero: the problem of ambiguous baseline conditions in fMRI

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Different brain networks mediate task performance in normal aging and AD: defining compensation.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Neocortical cell counts in normal human adult aging

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

New approaches in brain morphometry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-2626%2802%2900520-1

7 January 2021

10.1016/S0278-2626(02)00520-1

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

12480493